Andreas Struengmann & family

Andreas Struengmann & family

Andreas Struengmann & family (#300)

Global Rank #300
Country Rank #15
Country Germany

Andreas Struengmann & family is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 12 B
  • Pharmaceuticals
  • Germany
  • M
  • 76 Years

Snapshot

Quick Facts

Global Rank #300
Country Rank #15
Net Worth $11.6B
Previous Worth $11.6B
Worth Change +$0.0B
Country Germany
Industry Pharmaceuticals
Age 76 Years
Gender M
Worth As Of May 3, 2026
Last Refreshed 07 Sep 2026, 12:00 AM
Residence Tegernsee, Germany

Profile Data

Personal Stats

Age 76
Source Of Wealth Pharmaceuticals, Self Made
Residence Tegernsee, Germany
Citizenship Germany
Marital Status Married
Children 2
Education Medical Doctor, University at Buffalo
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $11.6B
Current Net Worth $11.6B

Worth as of May 3, 2026

About Me

Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19. The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion. The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding. In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.

Insights

Did You Know?

After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa.

Wealth Growth

Net Worth Growth Over Time

Tracking Andreas Struengmann & family's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $11.6B (May 3, 2026)